RCL

Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Docetaxel Injection, USP Due to Potential Presence of Particulate Matter

Risk Statement:  Intravenous administration of an injectable product that contains particulate matter may result in serious adverse events. Potential complications…

Sagent Pharmaceuticals May 28, 2024